Filana Therapeutics, Inc. (FLNA)
0.6355
-0.02
(-2.84%)
USD |
NASDAQ |
Oct 23, 16:00
0.6482
+0.01
(+2.00%)
After-Hours: 20:00
Filana Therapeutics Market Cap : 30.70M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 30.70M |
| October 22, 2026 | 31.60M |
| October 21, 2026 | 31.85M |
| October 20, 2026 | 33.26M |
| October 19, 2026 | 32.95M |
| October 16, 2026 | 33.98M |
| October 15, 2026 | 36.75M |
| October 14, 2026 | 35.34M |
| October 13, 2026 | 35.91M |
| October 12, 2026 | 37.17M |
| October 09, 2026 | 39.46M |
| October 08, 2026 | 39.30M |
| October 07, 2026 | 39.40M |
| October 06, 2026 | 42.26M |
| October 05, 2026 | 42.02M |
| October 02, 2026 | 44.97M |
| October 01, 2026 | 46.62M |
| September 30, 2026 | 42.80M |
| September 29, 2026 | 44.67M |
| September 28, 2026 | 41.22M |
| September 25, 2026 | 36.14M |
| September 24, 2026 | 37.33M |
| September 23, 2026 | 42.03M |
| September 22, 2026 | 49.76M |
| September 21, 2026 | 35.72M |
| Date | Value |
|---|---|
| September 18, 2026 | 35.07M |
| September 17, 2026 | 34.78M |
| September 16, 2026 | 33.05M |
| September 15, 2026 | 33.65M |
| September 14, 2026 | 34.72M |
| September 11, 2026 | 37.32M |
| September 10, 2026 | 39.08M |
| September 09, 2026 | 39.08M |
| September 08, 2026 | 38.51M |
| September 04, 2026 | 39.62M |
| September 03, 2026 | 40.01M |
| September 02, 2026 | 41.43M |
| September 01, 2026 | 41.41M |
| August 31, 2026 | 43.38M |
| August 28, 2026 | 44.88M |
| August 27, 2026 | 44.59M |
| August 26, 2026 | 44.66M |
| August 25, 2026 | 45.83M |
| August 24, 2026 | 44.93M |
| August 21, 2026 | 46.42M |
| August 20, 2026 | 45.53M |
| August 19, 2026 | 46.68M |
| August 18, 2026 | 41.88M |
| August 17, 2026 | 42.99M |
| August 14, 2026 | 44.12M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 609.69M |
| Eloxx Pharmaceuticals, Inc. | 51.67M |
| Breakthrough Chemistry, Inc. | 0.9243M |
| BioStem Technologies, Inc. | 27.98M |
| Cardiac Biotech Solutions, Inc. | 5.573M |
Market Cap Related Metrics
| Price to Book Value | 0.4826 |
| Price | 0.6355 |
| Earnings Yield | -137.7% |